S² Capital sets initial investment focus after first partners' meeting
S² Capital today announced the outcome of its first partners' meeting, held this morning from 10:00 to 11:00 Zurich time, at which the partners set the firm's initial investment focus.
The meeting departed from the previously published agenda, First partners' meeting: agenda, so that the partners could first align on the firm's current priorities.
- Markets: China A-shares, Hong Kong and the United States.
- Sector: healthcare, concentrating on chemical pharmaceuticals and biologics.
- Strategies to explore: fundamental value investing and event-driven investing.
The sector focus is an initial decision that builds on the partners' industry background and expertise.
The next partners' meeting is scheduled for November 2026. Its agenda will cover two topics:
- Fundamental value investing: a proposed shortlist of China A-share candidates, and an initial methodology for screening and segmenting Hong Kong and US stocks.
- Event-driven investing: a discussion of the strategy's methodology.